An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients

BACKGROUND: Peginesatide is a peptide-based erythropoiesis-stimulating agent that was designed and engineered to stimulate specifically the erythropoietin receptor dimer that governs erythropoiesis. The primary objective of this phase 2 dose-finding study was to determine the once-monthly peginesati...

Descripción completa

Detalles Bibliográficos
Autores principales: Besarab, Anatole, Zeig, Steven N, Martin, Edouard R, Pergola, Pablo E, Whittier, Frederick C, Zabaneh, Raja I, Schiller, Brigitte, Mayo, Martha, Francisco, Carol A, Polu, Krishna R, Duliege, Anne-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511162/
https://www.ncbi.nlm.nih.gov/pubmed/22935486
http://dx.doi.org/10.1186/1471-2369-13-95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511162/
https://www.ncbi.nlm.nih.gov/pubmed/22935486
http://dx.doi.org/10.1186/1471-2369-13-95

Ejemplares similares